A correlate of this antagonism in the context of liver cancer is the ability of LXRα agonists to limit the growth and expansion of HCC 3D spheroids, a phenotype positively regulated by CAFs when co-cultivated with HCC cells (Fig. 6). This evidence concerns the gene NR1H3 and liver cancer.